What AI says about Imcivree

Imcivree (setmelanotide) is a treatment for weight management in individuals with specific genetic obesity disorders, including Bardet-Biedl syndrome, POMC deficiency, and acquired hypothalamic obesity.

AI mentioned Imcivree from November 2025 to March 2026.